World's Best Scientists 2026 revealed!
Jonathan M. Schapiro

Jonathan M. Schapiro

D-Index & Metrics

Microbiology

D-Index
55
Citations
15777
World Ranking
3770
National Ranking
20

Overview

Jonathan M. Schapiro is affiliated with Sheba Medical Center in Israel. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with significant contributions in Infectious Diseases, Virology, Epidemiology, Hepatology, and Hematology.

The main topics covered by their work include:

  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • HIV/AIDS Research and Interventions
  • Hepatitis C virus research
  • Hepatitis B Virus Studies
  • Hemophilia Treatment and Research
  • Pneumocystis jirovecii pneumonia detection and treatment

Jonathan M. Schapiro has published numerous papers in various peer-reviewed journals. Some of the recent papers include:

  • Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis, 2021, AIDS
  • Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure, 2023, Clinical Infectious Diseases
  • Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study, 2023, The Lancet HIV
  • Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data, 2021, Haemophilia
  • Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment-limited individuals living with HIV, 2022, HIV Medicine

Frequent publication venues where Jonathan M. Schapiro's work appears include:

  • Clinical Infectious Diseases
  • The Lancet HIV
  • AIDS
  • Haemophilia
  • Journal of Antimicrobial Chemotherapy

Throughout their career, they have collaborated frequently with other researchers. Notable co-authors include:

  • Daniel R. Kuritzkes
  • Robert W. Shafer
  • Michael R. Jordan
  • Roger Paredes
  • Ravindra K. Gupta

Best Publications

  • Update of the Drug Resistance Mutations in HIV-1.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  • Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

    Diane E. Bennett;Ricardo J. Camacho;Dan Otelea;Daniel R. Kuritzkes

  • Drug-resistance genotyping in HIV-1 therapy: the VIRAD APT randomi sed controlled trial

    J. Durant;P. Clevenbergh;P. Halfon;P. Delgiudice

  • Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

    Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  • Update of the Drug Resistance Mutations in HIV-1: 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • HIV-1 drug resistance mutations: an updated framework for the second decade of HAART.

    Robert W. Shafer;Jonathan M. Schapiro

  • Clinical utility of HIV-1 genotyping and expert advice: the Havana trial.

    Cristina Tural;Lidia Ruiz;Christopher Holtzer;Jonathan Schapiro

  • HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance.

    Robert W. Shafer;Soo-Yon Rhee;Deenan Pillay;Veronica Miller

  • Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration

    Rami Kantor;David A Katzenstein;Brad Efron;Ana Patricia Carvalho

  • A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse transcriptase inhibitors.

    Bluma Brenner;Dan Turner;Maureen Oliveira;Daniela Moisi

  • Drug Resistance Mutations in HIV-1.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • The Effect of High-Dose Saquinavir on Viral Load and CD4+ T-Cell Counts in HIV-Infected Patients

    Jonathan M. Schapiro;Mark A. Winters;Fran Stewart;Bradley Efron

  • Frequency of Class I HLA-Restricted Anti-HIV CD8+ T Cells in Individuals Receiving Highly Active Antiretroviral Therapy (HAART)

    Clive M. Gray;Jody Lawrence;Jonathan M. Schapiro;John D. Altman;John D. Altman

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Patient compliance and drug failure in protease inhibitor monotherapy.

    Geertrui F. Vanhove;Jonathan M. Schapiro;Mark A. Winters;Thomas C. Merigan

  • Importance of protease inhibitor plasma levels in HIV-infected patients treated with genotypic-guided therapy: pharmacological data from the Viradapt Study.

    J Durant;P Clevenbergh;R Garraffo;P Halfon

  • Update of the drug resistance mutations in HIV-1: 2007.

    Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  • Update of the drug resistance mutations in HIV-1: December 2010.

    Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  • Update of the drug resistance mutations in HIV-1: Fall 2006.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Daniel R Kuritzkes

  • Update of the drug resistance mutations in HIV-1: Fall 2005.

    Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  • Update of the drug resistance mutations in HIV-1: December 2009.

    Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

Frequent Co-Authors

Robert W. Shafer
Robert W. Shafer Stanford University
Anne-Mieke Vandamme
Anne-Mieke Vandamme Rega Institute for Medical Research
Daniel R. Kuritzkes
Daniel R. Kuritzkes Brigham and Women's Hospital
Deenan Pillay
Deenan Pillay University College London
Charles A. Boucher
Charles A. Boucher Erasmus University Rotterdam
David Katzenstein
David Katzenstein Stanford University
Françoise Brun-Vézinet
Françoise Brun-Vézinet Université Paris Cité
Douglas D. Richman
Douglas D. Richman University of California, San Diego
Thomas C. Merigan
Thomas C. Merigan Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to a variety of career pathways, including healthcare, research, and information management. For those seeking flexible education options, exploring the best degrees for felons can be encouraging, as some online programs offer accessible routes for individuals with diverse backgrounds.

Healthcare roles such as a functional medicine np combine a strong knowledge of biology and patient care, enabling graduates to specialize in holistic treatment approaches. Additionally, careers in medical coding, like the certified professional coder, offer valuable positions in healthcare administration, translating complex medical information into standardized codes for efficient billing and records.

Another promising area is health information management, where professionals organize and safeguard patient data. Learning about the health information management job description and salary highlights the demand for experts who ensure compliance and accuracy in medical records systems.

Overall, a microbiology degree paired with specialized online certifications or degrees can lead to dynamic and rewarding careers across multiple sectors.

Best Scientists Citing Jonathan M. Schapiro

Trending Scientists

Recently Published Articles